AQST: Aquestive Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 416.68
Enterprise Value ($M) 369.92
Book Value ($M) -45.42
Book Value / Share -0.50
Price / Book -9.17
NCAV ($M) -58.81
NCAV / Share -0.64
Price / NCAV -7.09

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.59
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.91
Current Ratio 6.37

Balance Sheet (mrq) ($M)
Current Assets 96.57
Assets 109.96
Liabilities 155.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
4 days ago 13G/A Armistice Capital, Llc 2.93 -29.92
11-08 13G BlackRock, Inc. 6.40 0.00
04-01 13G Venrock Healthcare Capital Partners III, L.P. 6.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 461,752 1,531,837 30.14
2024-11-14 457,253 1,860,895 24.57
2024-11-13 298,669 961,302 31.07
2024-11-12 463,587 1,385,320 33.46

(click for more detail)

Similar Companies
ANIP – ANI Pharmaceuticals, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc.


Financial data and stock pages provided by
Fintel.io